Vol. 5 (10) pp. 1152-1156 DOI: 10.21474/IJAR01/5632

THE BETHESDA SYSTEM FOR REPORTING THYROID FINE NEEDLE ASPIRATES.

, , and
  • Post Graduate student, Department of Pathology, D.Y. Patil Medical College, Kolhapur.
  • Associate Professor, Department of Pathology, D.Y. Patil Medical College, Kolhapur.
9 Downloads 109 Views
Crossref

Download Full Paper (PDF)

Abstract

The Bethesda system for reporting thyroid cytopathology represents a major step towards standardization, reproducibility, improved clinical significance, and greater predictive value of thyroid fine needle aspirates (FNAs). This is a prospective study undertaken from May 2015 to April 2017 which included 72 clinically diagnosed cases of thyroid swellings who attended the D.Y. Patil Hospital and Research Institute, Kolhapur. Slides were stained with Haematoxylin and Eosin (H&E) and Pap smear. The microscopic diagnosis was interpreted under six categories of Bethesda. Of the 72 FNAs, 2.77% were non‑diagnostic, 87.5% were benign, 0% were atypical follicular lesion of undetermined significance (AFLUS), 4.16% were suspicious for follicular neoplasm (SFN), 0% were suspicious for malignancy (SM), and 5.5% malignant. Reviewing the thyroid FNAs with the Bethesda system allowed a more specific cytological diagnosis. TBSRTC is easy, flexible with option for descriptive diagnosis whenever required. It reduces inter observer variability in reporting thyroid FNAs.

Article Analytics

References

  1. K santosh, Mondal et al:The Bethesda system for reporting thyroid fine needle aspirates: journal of cytology/April 2013/Volume 30/Issue 2;244.
  2. S Edmund . Cibas, MD, and Z sayed . Ali, MD et al:The Bethesda System For Reporting Thyroid Cytopathology:American Society for Clinical Pathology/2009;132:655-58.
  3. Sameer Naz, Atif Ali Hashmi et al: Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology:BioMed.International Archiev of Medicine 2014,122-26.
  4. Mondal SK, Sinha S, Basak B, Roy DN, Sinha SK. The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up. J Cytol 2012;30(2):94-99.
  5. Yassa L, Cibas Es, Benson CB, Frates MC, Doubilet PM, Gawande AA, et al. Long-term Assessment of a Multidisciplinary Approach to Thyroid Nodule Diagnostic Evaluation. Cancer 2007;111(6):508-16.
  6. Thyroid Cytopathology: Bethesda and Beyond. Acta Cytol 2011;55:4-12.
  7. Jo VY, Stelow EB, Dustin SM, Hanley KZ. Malignancy Risk for Fine Needle Aspiration of Thyroid Lesions According to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2010;134:450-56.
  8. Renuka IV, Saila Bala G, Aparna C, Kumari R, Sumalatha K. The Bethesda System for Reporting Thyroid Cytopathology: Interpretation and Guidelines in surgical Treatment. Indian J Otolaryngol Head Neck Surg2012;64(4):305-11.
  9. Bhasin TS, Mannan R, Manjari M, Mehra M, Gill Sekhon AK, Chandey Metal. Reporoducibility of ?The Bethesda System for reporting Thyroid Cytopathology?: A Multi Center Study With Review of the Literature. J Clin Diagn Res 2013;7(6):1051-54.

How to Cite This Article

Sharma A, Shinde R.M, Deshpande T and Raghuwanshi P. (2017); THE BETHESDA SYSTEM FOR REPORTING THYROID FINE NEEDLE ASPIRATES., Int. J. of Adv. Res., 5 (10), 1152-1156, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/5632

Corresponding Author

Dr Anjay Sharma

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.